Zyla Life Sciences Long-Term Debt, Maturity, Year Three
Zyla Life Sciences had Long-Term Debt, Maturity, Year Three of $12.24 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2020-05-14
- 2020-03-31: Long-Term Debt, Maturity, Year Three $12.24M.
- 2019-12-31: Long-Term Debt, Maturity, Year Three $12.24M.
- 2019-09-30: Long-Term Debt, Maturity, Year Three $4.59M.
- 2019-06-30: Long-Term Debt, Maturity, Year Three $4.61M.
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2020-03-31 | $12.24M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $12.24M 10-K · filed 2020-03-26 |
| 2019-09-30 | $4.59M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $4.61M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $4.63M 10-Q · filed 2019-05-17 |
| 2017-12-31 | $27.94M 10-K · filed 2018-03-16 |
| 2016-12-31 | $16.00M 10-K · filed 2017-03-13 |
| 2015-12-31 | $4.53M 10-K · filed 2016-03-11 |